ArticleCureus2025
The Burden of Retinopathy of Prematurity in Albania: A Nationwide Observational Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRetinopathy of prematurity (ROP) is a vasoproliferative disorder of the developing retina and a leading cause of preventable childhood blindness. While data from high- and middle-income countries are well-documented, Albania has until now lacked national-level information on ROP incidence and severity.
objectiveThis study aimed to report the first national data on ROP screening outcomes in Albania and to assess the prevalence, severity, and clinical characteristics of ROP in preterm infants. The study also explores perinatal risk factors associated with the severity of ROP. Methods: A prospective observational study was conducted across neonatal intensive care units (NICUs) in Albania. A total of 173 preterm infants who met the international screening criteria (≤31 weeks gestational age (GA) or ≤1500 g birthweight (BW)) or with comorbidities underwent indirect ophthalmoscopy. Data regarding GA, BW, ROP stage, plus disease, and treatment requirements were collected and analyzed.
resultsOf the 173 infants screened, 88 (50.9%) had no ROP, 65 (37.6%) developed ROP of any stage, and 18 (10.4%) had incomplete data. Among the 65 infants with ROP, 45 (26.0%) had stages 1-2, 12 (6.9%) had stage ≥3, and 3 (1.7%) presented with plus disease. Infants with advanced ROP had a mean GA of 26.9 ± 1.3 weeks and a mean BW of 1313 ± 217 g. Severe ROP was significantly associated with both lower GA (p < 0.001) and BW (p < 0.001). Two infants with severe ROP required mechanical ventilation.
conclusionThis first national study demonstrates that more than one-third of preterm infants in Albania develop ROP, with nearly 7% progressing to advanced stages. The findings highlight the urgent need for a structured national screening program, improved neonatal care, and access to treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.